<code id='E1E01ABA3B'></code><style id='E1E01ABA3B'></style>
    • <acronym id='E1E01ABA3B'></acronym>
      <center id='E1E01ABA3B'><center id='E1E01ABA3B'><tfoot id='E1E01ABA3B'></tfoot></center><abbr id='E1E01ABA3B'><dir id='E1E01ABA3B'><tfoot id='E1E01ABA3B'></tfoot><noframes id='E1E01ABA3B'>

    • <optgroup id='E1E01ABA3B'><strike id='E1E01ABA3B'><sup id='E1E01ABA3B'></sup></strike><code id='E1E01ABA3B'></code></optgroup>
        1. <b id='E1E01ABA3B'><label id='E1E01ABA3B'><select id='E1E01ABA3B'><dt id='E1E01ABA3B'><span id='E1E01ABA3B'></span></dt></select></label></b><u id='E1E01ABA3B'></u>
          <i id='E1E01ABA3B'><strike id='E1E01ABA3B'><tt id='E1E01ABA3B'><pre id='E1E01ABA3B'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:4
          Fatty liver foregrounds arteries and veins surrounded by red blood cells — health coverage from STAT
          Adobe

          As drugmakers race to join the obesity drug market ignited by the approval of Wegovy and Zepbound, they’re not just competing on their drugs’ weight loss effects. They’re also competing on their products’ ability to treat a severe form of liver disease.

          A new update of the STAT Obesity Drug Tracker shows that at least 23 — about one-fifth — of the 105 obesity treatments in development or on the market are also being investigated for metabolic dysfunction-associated steatohepatitis, the fatty liver disease known as MASH (and previously called NASH).

          advertisement

          In this update, STAT has added a category — “other diseases investigated” — to show conditions beyond obesity for which a compound is being studied. Type 2 diabetes is the most common – it’s long been linked to obesity, and the latest GLP-1 treatments like Wegovy and Zepbound were initially developed as diabetes drugs. But behind diabetes, the next most common disease under investigation for obesity candidates is MASH.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
          Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

          AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

          read more
          Senate committee scrutinizes Medicare Advantage brokers
          Senate committee scrutinizes Medicare Advantage brokers

          Sen.RonWyden(D-Ore.)DrewAngerer/GettyImagesSenateFinanceCommitteemembersfrombothpartiestookaimWednes

          read more
          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more

          Will Ozempic

          Wegovy,theobesitydrug,wasinescapableattheObesityWeekconferenceinDallas.ElaineChenDALLAS—HereatObesit